The ARID1A subunit targets SWI/SNF complex to enhancers and loss of ARID1A impairs the enhancer-mediated transcriptional program of colonic epithelium and drives colon cancer in mice (Mathur et al., 2017). Here, ARID1A is linked to malignant colon neoplasm.